• 검색 결과가 없습니다.

Daclatasvir and asunaprevir combination therapy for patients with chronic hepatitis C virus genotype 1b infection in real world

N/A
N/A
Protected

Academic year: 2021

Share "Daclatasvir and asunaprevir combination therapy for patients with chronic hepatitis C virus genotype 1b infection in real world"

Copied!
8
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

수치

Table 1. Baseline characteristics of enrolled patients
Table 2. Univariate analysis of factors associated with failure  of sustained virologic response at 12 weeks after completion  of treatment
Table 3. Summary of adverse events (n = 216) Adverse events No. (%)

참조

관련 문서

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind,

- 우선, 외부 전원이 없는 회로, 즉 초기조건에 의해서 전류, 전압이 결정되 는 회로의 응답 : natural response.. - 다음, 직류 전압이나 전류가

(Background) The standard triple therapy used as the first-line treatment for Helicobacter pylori infection are a combination of proton pump inhibitor(PPI),

Median overall survival of 28 multiple myeloma patients treated with Cyclophosphamide-Prednisone combination regimens as a primary therapy was 115 weeks.. Median

Seven patients underwent H. pyroli eradication therapy. Three patients showed complete response, but four patients failed... Conclusion

3 Mean percentages of bone implant contact ratio in the control group and experimental groups at 6 and 12 weeks after placement of the

It was summarized as follows that group participating in after-school basketball activities for 12 weeks showed decrease of the body fat(%) and increase

Full genome cloning and nucleotide sequence analysis of hepatitis C virus from sera of chronic hepatitis patients in Korea. Detection of hepatitis C virus RNA